Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001742496-26-000005
Filing Date
2026-06-01
Accepted
2026-06-01 20:00:12
Documents
1
Period of Report
2026-05-28

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primarydocument.html 4  
1 PRIMARY DOCUMENT primarydocument.xml 4 9153
  Complete submission text file 0001742496-26-000005.txt   10513
Mailing Address 450 EAST 29TH STREET, 16TH FLOOR NEW YORK NY 10016
Business Address
Moss Gregory S. (Reporting) CIK: 0001742496 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-42938 | Film No.: 261053194

Mailing Address 1891 PAGE MILL RD PALO ALTO CA
Business Address 1891 PAGE MILL RD PALO ALTO CA (650) 223-7745
Evommune, Inc. (Issuer) CIK: 0002044725 (see all company filings)

EIN.: 850742575 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)